CardioLogs ECG Analysis Platform vs A View LCS

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CardioLogs (acquired by Philips in 2021)
VS
by Coreline Soft

AI Verdict

Tool A specializes in AI-powered analysis of ECG data for arrhythmia detection, focusing on the electrical activity of the heart. In contrast, Tool B provides AI-driven analysis of thoracic CT scans for lung cancer screening, emphysema quantification, and coronary artery calcification detection, addressing structural and anatomical aspects. While both contribute to cardiovascular health assessment, they utilize fundamentally different diagnostic modalities and target distinct clinical problems.

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your primary need is rapid, AI-driven analysis of ECG data from a variety of cardiac monitoring devices to aid in the detection and diagnosis of arrhythmias. This platform is ideal for cardiology practices seeking to streamline their workflow and enhance diagnostic accuracy for conditions like AFib and VT through cloud-based, medical-grade AI.

View CardioLogs ECG Analysis Platform →

Choose A View LCS if…

Choose AVIEW LCS if your focus is on comprehensive AI-powered analysis of thoracic CT scans for lung cancer screening, emphysema quantification, and coronary artery calcification detection. This solution is best suited for radiology departments and oncology centers requiring automated, detailed reporting and risk assessment for multiple thoracic conditions from a single low-dose CT scan.

View A View LCS →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform A View LCS
Deployment Cloud-based Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker). It can also be integrated into standard reading environments (PACS), RIS (Radiological Information System), or used as a standalone third-party application or web-based application.
FDA Status 1 AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CardioLogs ECG Analysis Platform

Tool A, CardioLogs, offers a pure cloud-based (SaaS) platform with multi-device compatibility and EHR integration, suggesting a streamlined and accessible user experience. Its 'at any time, from any computer' approach with an ergonomic interface prioritizes ease of use for clinicians.

Clinical Value

A View LCS

Tool B, A View LCS, provides comprehensive thoracic CT analysis, detecting lung cancer, emphysema, and coronary artery calcification from a single low-dose CT scan. This multi-faceted diagnostic capability, addressing three major diseases simultaneously, offers a broader and more holistic clinical value per patient interaction compared to Tool A's focused ECG analysis.

Pricing & Value

CardioLogs ECG Analysis Platform

Tool A, CardioLogs, offers a transparent 'Pay per ECG regardless of the number of users' pricing model, allowing for predictable costs based on usage. Tool B's pricing is less transparent, requiring direct contact for a quote, which makes it harder to assess immediate value.

Enterprise Readiness

A View LCS

Both tools are FDA-cleared and HIPAA compliant, indicating strong regulatory readiness. However, Tool B, A View LCS, offers significantly more flexible deployment options, including cloud, hybrid, on-premise, and virtualized solutions, which is crucial for large enterprises with diverse IT infrastructures and data governance needs.

Innovation

CardioLogs ECG Analysis Platform

Tool A, CardioLogs, is noted for 'reinventing cardiology diagnostics with medical-grade AI and cloud technology,' leveraging deep neural networks for ECG analysis and supporting data from consumer wearables like smartwatches. It was also the first FDA-cleared AI solution for ECG analysis in 2017, demonstrating pioneering innovation in the field.

Support & Docs

Tie

Both companies provide clear avenues for support and documentation. CardioLogs offers technical support via its platform, a dedicated support center, and various clinical and product documents. Coreline Soft provides direct customer service contacts and makes expert consultations and technical documentation available. Neither demonstrates a clear advantage in the publicly available information regarding the breadth or depth of their support and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform A View LCS
Tool Name CardioLogs ECG Analysis Platform A View LCS
Company Cardiologs Technologies (now part of Philips) Coreline Soft Co.
Primary Application/Focus ECG data analysis for arrhythmia detection and diagnosis. Comprehensive thoracic CT analysis for lung cancer screening, emphysema quantification, and coronary artery calcification detection.
Key AI Functionality AI-Powered ECG Analysis (Deep Neural Networks), Automated Arrhythmia Detection (e.g., AFib, VT), Multi-Device Compatibility (Holter, smartwatches, ECG patches) Automated lung nodule detection and classification, Emphysema analysis and quantification (LAA), Coronary Artery Calcium (CAC) scoring
Supported Medical Modality/Data Type ECG data from various cardiac monitoring devices Thoracic CT scans

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and A View LCS.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

CardioLogs ECG Analysis Platform analyzes ECG data from various cardiac monitoring devices, including Holter monitors, smartwatches, and ECG patches. AVIEW LCS, on the other hand, specializes in analyzing thoracic CT images, particularly low-dose CT scans.
CardioLogs ECG Analysis Platform focuses on rapid, accurate, and efficient arrhythmia detection and diagnosis from ECG data, such as AFib and VT. AVIEW LCS provides comprehensive thoracic CT analysis for lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single CT scan.
CardioLogs ECG Analysis Platform operates on a 'pay per ECG' pricing model, irrespective of the number of users. For AVIEW LCS, pricing information requires contacting sales for a customized quote.
Both tools are relevant for Cardiology. Additionally, CardioLogs ECG Analysis Platform serves Emergency Medicine and Internal Medicine. AVIEW LCS is primarily designed for Pulmonology and Radiology, alongside Cardiology.
CardioLogs ECG Analysis Platform uses deep neural networks for automated arrhythmia detection and generates customizable reports. AVIEW LCS provides automated lung nodule detection and classification, 3D volume quantification, Lung-RADS scoring, emphysema analysis (LAA), coronary artery calcium (CAC) scoring (Agatston, volume, mass), and automated comprehensive report generation in various formats.
AI Tool Finder
AI-powered search. Results may not be comprehensive.